Proliferative activity of microvascular cells in glioblastomas does not correlate with time to recurrence

Journal of Neuro-Oncology

Volumn 63, Issue 1, 2003, Pages 9-13

  Kern, Michael A ^a   Feisel, Klaus D ^a   Friese, Michael ^a   Ernestus, Ralf Ingo ^a   Schröder, Roland ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Angiogenesis; Glioblastoma; MIB 1 labeling index; Proliferation of microvascular cells; Time to recurrence; Tumor cell proliferation

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GLIOBLASTOMA; HUMAN; LABELING INDEX; MALE; MICROVASCULATURE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037868858     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023795417525     Document Type: Article

References (22)

1. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285: 1182-1186, 1971
2. Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. WHO Classification of Tumours. International Agency for Research on Cancer, Lyon, 2000
3. Leon SP, Folkerth RD, Black PMcL: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372, 1996
4. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I: Microvessel density in brain tumors. Anticancer Res 17: 4747-4754, 1997
5. Chan ASY, Leung SY, Wong MP, Yuen ST, Cheung N, Fan YW, Chung LP: Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 22: 816-826, 1998
6. Wesseling P, Van Der Laak JAWM, Link M, Teepen HLJM, Ruiter DJ: Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol 29: 352-358, 1998
7. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML: Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 88: 513-520, 1998
8. Wesseling P, Van Der Laak JAWM, De Leeuw H, Ruiter DJ, Burger PC: Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 81: 902-909, 1994
9. Nagashima T, Hoshino T, Cho KG: Proliferative potential of vascular components in human glioblastoma multiforme. Acta Neuropathol 73: 301-305, 1987
10. Yoshii Y, Sugiyama K: Intercapillary distance in the proliferating area of human glioma. Cancer Res 48: 2938-2941, 1988
11. Watanabe K, Ogata N, Von Ammon K, Yonekawa Y, Nagai M, Ohgaki H, Kleihues P: Immunohistochemical assessment of P53 protein accumulation and tumor growth fraction during the progression of astrocytomas. In: Nagai M (ed) Brain Tumor. Research and Therapy. Springer, Tokyo, Berlin, Heidelberg, New York, Barcelona, Budapest, Hong Kong, London, Milan, Paris, 1996, pp 255-262
12. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H: Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res 16: 153-157, 1997
13. Schröder R, Feisel KD, Ernestus R-K: Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. J Neuro-Oncol 56: 127-132, 2002
14. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR: The labeling of proliferating cells by Ki-67 and MIB-1 antibodies depends on the binding of a nuclear protein to DNA. Exp Cell Res 210: 145-153, 1994
15. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T: Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921-1926, 1994
16. Torp SH: Proliferative activity in human glioblastomas: Evaluation of different Ki 67 equivalent antibodies. J Clin Pathol: Mol Pathol 50: 198-200, 1997
17. Groothuis DR, Fischer JM, Vick NA, Bigner DD: Experimental gliomas: An autoradiographic study of the endothelial component. Neurology 30: 297-301, 1980
18. Brien SE, Zagzag D, Brem S: Rapid in situ cellular kinetics of intracerebral tumor angiogenesis using a monoclonal antibody to bromodeoxyuridine. Neurosurgery 25: 715-719, 1989
19. McComb RD, Jones TR, Pizzo SV, Bigner DD: Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and in mixed glioma-sarcoma. J Neuropathol Exp Neurol 41: 479-489, 1982
20. Haddad SF, Moore SA, Schelper RL, Goeken JA: Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51: 488-492, 1992
21. Wesseling P, Schlingemann RO, Rietveld FJR, Link M, Burger PC, Ruiter DJ: Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol 54: 304-310, 1995
22. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, Westphal M, Lamszus K: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61: 6624-6628, 2001